52 FR 3684 NOTICES DEPARTMENT OF COMMERCE [C-508-605] Preliminary Affirmative Countervailing Duty Determination; Industrial Phosphoric Acid From Israel Thursday, February 5, 1987 *3684 AGENCY: Import Administration, International Trade Administration, Commerce. ACTION: Notice. SUMMARY: We preliminarily determine that benefits which constitute subsidies within the meaning of the countervailing duty law are being provided to manufacturers, producers, or exporters in Israel of industrial phosphoric acid. The estimated net subsidy is 6.52 percent ad valorem for Negev Phosphates Ltd., 14.83 percent ad valorem for Haifa Chemicals Ltd., and 7.14 percent ad valorem for all other manufacturers, producers, or exporters in Israel of industrial phosphoric acid. In addition, we preliminarily determine that critical circumstances do not exist in this case. We have notified the U.S. International Trade Commission (ITC) of our determination. We are directing the U.S. Customs Service to suspend liquidation of all entries of industrial phosphoric acid from Israel that are entered, or withdrawn from warehouse, for consumption on or after the date of publication of this notice and to require a cash deposit or bond on entries of the subject merchandise in an amount equal to the estimated net subsidy as described in the "Suspension of Liquidation" section of this notice. If this investigation proceeds normally, we will make our final determination by April 14, 1987. EFFECTIVE DATE: February 5, 1987. FOR FURTHER INFORMATION CONTACT:David Levine or Gary Taverman, Office of Investigations, Import Administration, International Trade Administration, U.S. Department of Commerce, 14th Street and Constitution Avenue, NW., Washington, DC 20230; telephone: 202/377-1673 (Levine), 202/377-0161 (Taverman). *3685 SUPPLEMENTARY INFORMATION: . Preliminary Determination Based upon our investigation, we preliminarily determine that benefits which constitute subsidies within the meaning of section 701 of the Tariff Act of 1930, as amended (the Act), are being provided to manufacturers, producers, or exporters in Israel of industrial phosphoric acid. For purposes of this investigation, the following programs are found to confer subsidies to manufacturers, producers, or exporters of industrial phosphoric acid in Israel: - Investment Grants under the Encouragement of Capital Investments Law (ECIL) - Long-Term Development Loans under the ECIL - Bank of Israel Export Production Fund loans - Bank of Israel Export Shipment Fund Loans - Bank of Israel Imports-for-Export Fund Loans - Exchange Rate Risk Insurance Scheme Case History On November 5, 1986, we received a petition in proper form filed by the FMC Corporation, of Philadelphia, Pennsylvania, and the Monsanto Company, of Saint Louis, Missouri, on behalf of the U.S. industry producing industrial phosphoric acid. In compliance with the filing requirements of § 355.26 of the Commerce Regulations (19 CFR 355.26), the petition alleges that manufacturers, producers, or exporters in Israel of industrial phosphoric acid receive, directly or indirectly, subsidies within the meaning of section 701 of the Act, and that these imports materially injure, or threaten material injury to, a U.S. industry. In addition, the petition alleges that "critical circumstances," as defined in section 703(e)(1) of the Act, exist in this case. We found that the petition contained sufficient grounds upon which to initiate a countervailing duty investigation, and on November 25, 1986, we initiated such an investigation (51 FR 43761, December 4, 1986). We stated that we expected to issue a preliminary determination by January 29, 1987. Since Israel is a "country under the Agreement" under section 701(b) of the Act, the ITC is required to determine whether imports of the subject merchandise from Israel materially injure, or threaten material injury to, a U.S. industry. Therefore, we notified the ITC of our initiation. On December 22, 1986, the ITC determined that there is a reasonable indication that an industry in the United States is materially injured by reason of imports from Israel of industrial phosphoric acid (52 FR 612, January 7, 1987). On December 8, 1986, we presented a questionnaire to the Government of Israel in Washington, DC concerning the petitioners' allegations, and requested a response by January 5, 1987. On December 30, 1986, upon request of respondents, we granted additional time to submit responses. On January 12, 1987, we received responses to our questionnaire from the Government of Israel and from Negev Phosphates Ltd. (Negev). We did not receive a response from Haifa Chemicals Ltd. (Haifa), although it is a producer and exporter of industrial phosphoric acid. For purposes of this preliminary determination, we therefore applied the best information available to derive an estimated countervailing duty rate for Haifa. As best information available, we used the subsidy rates for particular programs found in our most recent final affirmative countervailing duty determination for an industrial product from Israel (Final Affirmative Countervailing Duty Determination: Oil Country Tubular Goods from Israel (OCTG) (52 FR 1649, January 15, 1987)), or the rate found for Negev, whichever was greater. Because Haifa did not respond, we preliminarily determine that a significant difference exists in the estimated net subsidies for the two companies. We therefore found company- specific rates for Haifa and Negev, and derived a weighted average for the "all other" company rate for insustrial phosphoric acid from Israel. Scope of Investigation The product covered by this investigation is industrial phosphoric acid, which is currently provided for in item 416.30 of the Tariff Schedules of the United States (TSUS). Analysis of Programs Throughout this notice, we refer to certain general principles applied to the facts of the current investigation. These principles are described in the "Subsidies Appendix" attached to the notice of Cold-Rolled Carbon Steel Flat- Rolled Products from Argentina; Final Affirmative Countervailing Duty Determination and Countervailing Duty Order (49 FR 18006, April 26, 1984). Consistent with our practice in preliminary determinations, when a response to an allegation denies the existence of a program, receipt of benefits under a program, or eligibility of a company or industry under a program, and the Department has no persuasive evidence showing that the response is incorrect, we accept the response for purposes of the preliminary determination. All such responses are subject to verification. If the response cannot be supported at verification, and the program is otherwise countervailable, the program will be considered a subsidy in the final determination. For purposes of this preliminary determination, the period for which we are measuring subsidization ("the review period") is April 1, 1985 through March 31, 1986, the fiscal year for the companies under investigation. In their responses, the Government of Israel and Negev provided data, including financial statements, for the applicable period. Based upon our analysis of the petition and the responses to our questionnaire, we preliminarily determine the following: I. Programs Preliminarily Determined to Confer Subsidies We preliminarily determine that subsidies are being provided to manufacturers, producers, or exporters of industrial phosphoric acid in Israel under the following programs. A. The Encouragement of Capital Investments Law (ECIL) The purpose of the ECIL is to attract capital to Israel. In order to be eligible to receive various benefits under the ECIL, including investment grants, long-term industrial development loans, accelerated depreciation, and reduced tax rates, the applicant must obtain approved enterprise status. Approved enterprise status is obtained after review of information submitted to the Israel Ministry of Industry and Trade, Investment Center Division. The amount of the benefits received by approved enterprises depends on the geographic location of the eligible enterprise. For purposes of the ECIL, Israel is divided into three zones--Development Zone A, Development Zone B, and the "central area"--each with a different funding level. 1. Investment Grants. According to the responses, only investment projects outside the central area are eligible to receive investment grants since 1978. Because the grants are limited to enterprises located in specific regions, we preliminarily determine that they constitute subsidies within the meaning of the Act. Since 1975, Negev has been approved to receive grants for two projects. To calculate the benefit, we allocated these grants over 10 years (the average useful life of assets in the chemical manufacturing industry, as determined under the U.S. Internal Revenue *3686 Service's Asset Depreciation Range System). Usually, to allocate benefits over time we use as our discount rate the firm's weighted cost of capital, which is an average of the company's marginal costs of debt and equity for the year in which the terms of the grant were approved. However, we were unable to calculate a weighted cost of capital for Negev because there is no fixed rate long-term borrowing in Israel. Therefore, in order to reflect most accurately the benefit to Negev over time, we have used a variable discount rate to allocate the grant benefits. To calculate the grant allocation amount for the review period, we applied the grant methodology outlined in the Subsidies Appendix, using as our variable discount rate the national average short-term borrowing rate for new Israeli shekels (NIS) in the review period, as determined by the Bank of Israel, adjusted for inflation. We divided by the value of total sales during the review period to calculate an estimated net subsidy for Negev of 2.1 percent ad valorem. As best information available, we preliminarily determine that the estimated net subsidy for Haifa also is 2.1 percent ad valorem. 2. Long-Term Industrial Development Loans. Prior to July 1985, approved enterprises were eligible to receive long-term industrial development loans funded by the Government of Israel. These loans were disbursed through the Industrial Development Bank of Israel (IDBI) and other industrial development banks associated with each commercial bank in Israel. We stated in OCTG that the Government of Israel did not provide us with sufficient information concerning selection criteria for approved enterprises under ECIL, the criteria for receiving industrial development loans under ECIL, or the distribution of loans under the program. Although we asked for explanations of these elements in our questionnaire for the instant case, the responses did not provide sufficient clarification. Therefore, we preliminarily determine that the loans are limited to a specific enterprise or industry, or group of enterprises or industries, and are countervailable if they were provided on terms inconsistent with commercial considerations. The supplemental response of Negev indicates that the company had loans under this program outstanding during the review period for projects at five of its plants, one of which produces an input for the subject product. The loans provided for this plant were linked to the U.S. dollar and were not on terms inconsistent with commercial considerations; i.e., interest paid on the loans was not less than what would have been paid at our benchmark rate for these loans (the dollar-linked variable short-term rate adjusted for exchange rate fluctuation). Therefore, we preliminarily determine that Negev received no countervailable benefits under this program. As best information available, we preliminarily determine the estimated net subsidy for Haifa to be 5.02 percent ad valorem, based on OCTG. B. Bank of Israel Export Loans The Government of Israel provides preferential financing to manufacturers, producers, or exporters in Israel of industrial phosphoric acid through three export credit funds administered by the Bank of Israel (BOI). 1. Export Production Fund (EPF). Under the EPF, three-month loans are provided to exporters to finance export production. The amount which a company is able to borrow under this program is limited by a quota set by the BOI. The quota is based on the value of the company's exports, the product's value-added percentage, and the production cycle of the company. During the review period, Negev received loans denominated in NIS under this program. Because only exporters are eligible for these loans, we preliminarily determine that they are countervailable to the extent that they are provided at preferential rates. We used as our benchmark the national average non-directed short-term NIS lending rate in the review period, to be published in the 1986 BOI Annual Report, [FN1] adjusted for inflation. Comparing this benchmark to the interest rates charged on these loans, we preliminarily determine that the loans were provided at preferential rates and are, therefore, countervailable. FN1 We received this public information during verification for our Final Affirmative Countervailing Duty Determination: Certain Fresh Cut Flowers from Isreal (Flowers) (to be published in the Federal Register on February 3, 1987). It is contained in Verification Exhibit 20 of the official file (C-508-603). To calculate the benefit from these loans, we allocated the interest savings over total exports during the review period, because Negev did not segregate loans provided for industrial phosphoric acid from loans for other products. We thereby calculated an estimated net subsidy of 0.64 percent ad valorem for Negev. The estimated net subsidy for Haifa is 2.78 percent ad valorem, based on OCTG. 2. Export Shipment Fund (ESF). Under the ESF, loans are provided to exporters to enable them to extend credit in foreign currency to their overseas customers. Financing is granted on a shipment-by-shipment basis. Funding is provided after shipment of the goods and must be repaid within six months. Because only exporters are eligible for these loans, we preliminarily determine that they are countervailable to the extent that they are provided at preferential rates. According to its response, Negev received only dollar-denominated loans under the ESF at the interest rate of LIBOR plus two percent. Dollar loans are not otherwise available in Israel, and we were not able to obtain a benchmark interest rate for these loans from independent sources. We therefore used the benchmark applied in our Final Affirmative Countervailing Duty Determination: Potassium Chloride from Israel (Potash) (49 FR 36122, September 14, 1984) and OCTG, which is the London Interbank Offered Rate (LIBOR) plus two percent. Since Negev paid interest on the loans at our benchmark rate, we preliminarily determine that the company received no countervailable benefits under the ESF. The estimated net subsidy for Haifa is 0.002 percent ad valorem, based on OCTG. 3. Imports-for-Export Fund (IEF). Under the IEF, exporters receive loans with a three-month term in order to finance imported materials used for export production. Because only exporters are eligible for these loans, we determine that they are countervailable to the extent that they provided at preferential rates. According to its response, Negev received dollar-denominated loans under the IEF during the review period. Comparing the benchmark interest rate (LIBOR plus two percent) to the rates charged on these loans, we preliminarily determine that some of the loans were provided at preferential rates and are, therefore, countervailable. To calculate the benefit from these loans, we allocated the interest savings over total exports during the review period, since Negev did not segregate loans for industrial phosphoric acid from loans for other products. We thereby calculated an estimated net subsidy of 0.01 percent ad valorem for Negev. The estimated net subsidy for Haifa is 1.16 percent ad valorem, based on OCTG.D. Exchange Rate Risk Insurance Scheme The Exchange Rate Risk Insurance Scheme (EIS), operated by the Israel Foreign Trade Risk Insurance Corporation Ltd. (IFTRIC), is aimed at insuring exporters against losses which result when the rate of inflation exceeds the rate of devaluation and the new Israeli shekel (NIS) value of an exporter's foreign currency receivables does not rise enough to cover increases in local costs. The EIS scheme is optional and open to any exporter willing to pay a premium to IFTRIC. Compensation is based on a comparison of the change in the rate of devaluation of the NIS against a basket of foreign currencies with the change in the consumer price index. If the rate of inflation is greater than the rate of devaluation, the exporter is compensated by an amount equal to the difference between these two rates multiplied by the value-added of the exports. If the rate of devaluation is higher than the change in the domestic price index, however, the exporter must compensate IFTRIC. The premium is calculated on the basis of the value-added of the exports. In determining whether an export insurance program provides a countervailable benefit, we examine whether the premiums and other charges are adequate to cover the program's long-term operating costs and losses. In Potash, we stated that we had insufficient data to determine that the premiums and other charges were manifestly inadequate to cover the program's long-term operating costs and losses. We noted, however, that we were not making a conclusive determination on the program's countervailability at that time. However, in OCTG and Flowers we found that this program conferred a countervailable benefit on manufacturers, producers, or exporters in Israel of oil country tubular goods and flowers. In both those cases we reviewed EIS data which showed that EIS operated at a loss from 1981 through 1985. In fact, in the five years of operations, there was only one month when premiums received were greater than compensation paid out. We believe that five years is, in this case, a sufficiently long period to establish that the premiums and other charges are manifestly inadequate to cover the long-term operating costs and losses of the program. Therefore, we preliminarily determine that this program confers an export subsidy on exports of industrial phosphoric acid from Israel. We calculated the benefit from this program by allocating the amount of compensation Negev received from IFTRIC expressly for industrial phosphoric acid exported to the United States, after deducting premiums paid, over the company's exports of industrial phosphoric acid to the United States during the review period. We thereby found a estimated net subsidy of 3.77 percent ad valorem for Negev. As best information available, we preliminarily determine that the estimated net subsidy for Haifa also is 3.77 percent ad valorem. II. Programs Preliminarily Determined Not to be Used We preliminarily determine that the following programs were not used by manufacturers, producers, or exporters in Israel of industrial phosphoric acid during the review period. A. Encouragement of Industrial Research and Development Law (EIRD) Petitioners allege that manufacturers, producers, or exporters in Israel of industrial phosphoric acid may benefit from research and development grants. Negev's response states that the company received no grants for research and development related to its production of industrial phosphoric acid. B. Foreign Investment Company Benefits Petitioners allege that under Amendment 15 to the ECIL a "Foreign Investment Company" is entitled to certain grants. Negev's response indicates that the company did not qualify for any benefits under this law. C. Export Promotion Fund Benefits Petitioners allege that exporters in Israel may receive benefits under this program. Negev's response indicates that it receives foreign currency loans under this program to establish a Paris office, but that it received no other benefits. III. Program Preliminarily Determined to be Terminated We preliminarily determine that the following program has been terminated. A. Property Tax Exemptions on Buildings and Equipment Petitioners allege that manufacturers, producers, or exporters in Israel of industrial phosphoric acid may benefit from tax incentives that allow eligible enterprises a five-year exemption from payment of two-thirds of property taxes on buildings and a ten-year exemption for payment of one-sixth of property taxes on equipment. According to the responses and our determinations in OCTG and Potash, the exemptions were repealed by Amendment No. 17, ECIL, 5738-1979. Also, property taxes on industrial buildings and equipment were repealed for all taxpayers in Israel on April 1, 1981. Property tax exemptions referred to in Section 53 of the ECIL are taxes on apartment buildings in residential areas. IV. Programs for Which We Need Additional Information We preliminarily determine that we need additional information in order to analyze accurately the following programs. A. Preferential Accelerated Depreciation Under section 42 of the ECIL, a company which has obtained approval enterprise status can choose to depreciate machinery and equipment at double the normal rate and buildings at four times the normal rate. Based on the responses, it is unclear whether Negev used accelerated depreciation under this law, or whether such accelerated depreciation is available to more than a specific enterprise or industry, or group of enterprises or industries. We therefore preliminarily determine that we need additional information to make a determination regarding this program. B. Other ECIL Tax Benefits Under Section 47 of the ECIL, a company which has obtained approved enterprise status is eligible for a reduced corporate and income tax rate. For the reasons provided in IV.A. above, we need additional information to make a determination regarding this program. C. The Encouragement of Industry Law (EIL) Accelerated Depreciation and Further Tax Reductions Petitioners allege that manufacturers, producers or exporters in Israel of industrial phosphoric acid may receive accelerated depreciation and further tax reductions under the EIL. For the reasons stated in IV.A. above, we need additional information to make a determination regarding this program. Critical Circumstances Petitioners allege that "critical circumstances" exist within the meaning of section 703(e)(1) of the Act, with respect to imports of industrial phosphoric acid from Israel. In determining whether critical circumstances exist, we must examine whether there is a reasonable basis to believe or suspect that: (1) The alleged subsidy is inconsistent with the Agreement, and (2) there have been massive imports of the subject merchandise over a relatively short period. In determining whether imports have been massive over a relatively short period of time, we have considered the following factors: (1) the volume and value of the imports; (2) seasonal trends; and (3) the share of domestic consumption accounted for by the imports. A review of this information *3687 indicates that imports from Israel have not been massive over a relatively short period of time. Since we have not found massive imports over a relatively short period of time, we do not need to consider whether the alleged subsidies are inconsistent with the Agreement. Therefore, we preliminarily determine that critical circumstances do not exist. Verification In accordance with section 776(a) of the Act, we will verify the data used in making our final determination. We will not accept any statement in a response that cannot be verified for our final determination. Suspension of Liquidation In accordance with section 703(d) of the Act, we are directing the U.S. Customs Service to suspend liquidation of all entries of industrial phosphoric acid from Israel which are entered, or withdrawn from warehouse, for consumption on or after the date of publication of this notice in the Federal Register, and to require a cash deposit or bond for each such entry of this merchandise equal to 6.52 percent ad valorem for Negev Phosphates Ltd., 14.83 percent ad valorem for Haifa Chemicals Ltd., and 7.14 percent ad valorem for all other companies in Israel. ITC Notification In accordance with section 703(f) of the Act, we will notify the ITC of our determination. In addition, we are making available to the ITC all nonprivileged and nonproprietary information relating to this investigation. We will allow the ITC access to all privileged and proprietary information in our files, provided the ITC confirms that it will not disclose such information, either publicly or under an administrative protective order, without the written consent of the Deputy Assistant Secretary for Import Administration. If our final determination is affirmative, the ITC will determine whether these imports materially injure, or threaten material injury to, a U.S. industry within 45 days after the Department makes its final determation. Public Comment In accordance with § 355.35 of the Commerce Regulations (19 CFR 355.35) we will hold a public hearing, if requested, to afford interested parties an opportunity to comment on this preliminary determination, at 10:00 a.m. on March 12, 1987, at the U.S. Department of Commerce, Room 3708, 14th Street and Constitution Avenue, NW., Washington, DC 20230. Individuals who wish to participate in the hearing must submit a request to the Deputy Assistant Secretary, Import Administration, Room B-099, at the above address within 10 days of the publication of this notice in the Federal Register. Requests should contain: (1) The party's name, address, and telephone number; (2) the number of participants; (3) the reason for attending; and (4) a list of the issues to be discussed. In addition, at least 10 copies of the proprietary version and seven copies of the nonproprietary version of the pre-hearing briefs must be submitted to the Deputy Assistant Secretary by March 5, 1987. Oral presentations will be limited to issues raised in the briefs. In accordance with 19 CFR 355.33(d) and 19 CFR 355.34, all written views will be considered if received not less than 30 days before the final determination is due, or, if a hearing is held, within 10 days after the hearing transcript is available. This determination is published pursuant to section 703(f) of the Act (19 U.S.C. 1671b(f)). Joseph A. Spetrini, Acting Deputy Assistant Secretary for Import Administration. January 29, 1987. [FR Doc. 87-2430 Filed 2-4-87; 8:45 am] BILLING CODE 3510-DS-M